OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint inhibitor induced colitis: A nationwide population-based study
Natalie Farha, Motasem Alkhayyat, Adrian Lindsey, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 46, Iss. 1, pp. 101778-101778
Closed Access | Times Cited: 12

Showing 12 citing articles:

Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling
Jian Yang, Jialuo He, Yiting Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Immune-mediated colitis after immune checkpoint inhibitor therapy
Sophie Giesler, R. Kirk Riemer, Theresa Lowinus, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 4

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Mar Riveiro‐Barciela, Sabela Carballal, Álvaro Díaz‐González, et al.
Gastroenterología y Hepatología (2024) Vol. 47, Iss. 4, pp. 401-432
Open Access | Times Cited: 3

Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their Management
Rocío Sedaño, Daniel Cabrera, Andrea Jiménez, et al.
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 12, pp. 1917-1932
Closed Access | Times Cited: 12

Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
Genesis Perez Del Nogal, Neha U. Patel
ACG Case Reports Journal (2022) Vol. 9, Iss. 12, pp. e00946-e00946
Open Access | Times Cited: 11

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
Valérie Desmedt, Aranzazu Jauregui-Amezaga, Liselotte Fierens, et al.
European Journal of Cancer (2023) Vol. 187, pp. 36-57
Closed Access | Times Cited: 6

Immunotherapy-induced Colitis
Haleh Vaziri, Alla Turshudzhyan, Eric Vecchio
Journal of Clinical Gastroenterology (2022) Vol. 56, Iss. 7, pp. 555-564
Closed Access | Times Cited: 9

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU
Mar Riveiro‐Barciela, Sabela Carballal, Álvaro Díaz‐González, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access | Times Cited: 1

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Mar Riveiro‐Barciela, Sabela Carballal, Álvaro Díaz‐González, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 4, pp. 401-432
Open Access | Times Cited: 1

Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know
M. Robinson, Mairéad G. McNamara, H.W. Clouston, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3781-3781
Open Access | Times Cited: 2

Page 1

Scroll to top